BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3500221)

  • 1. Lymphokine-activated killer (LAK) cells. III. Characterization of LAK precursors and susceptible target cells within the murine thymus.
    Ballas ZK; Rasmussen W
    J Immunol; 1987 Nov; 139(10):3542-9. PubMed ID: 3500221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of mouse thymocyte-derived, interleukin 2-activated killer cells and their precursors.
    Yagi H; Nishimura T; Hashimoto Y
    Jpn J Cancer Res; 1987 Jul; 78(7):721-8. PubMed ID: 3114198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of lymphokine-activated killer cell activity from human thymocytes.
    Ramsdell FJ; Golub SH
    J Immunol; 1987 Sep; 139(5):1446-53. PubMed ID: 2442246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphokine-activated killer (LAK) cells. IV. Characterization of murine LAK effector subpopulations.
    Ballas ZK; Rasmussen W
    J Immunol; 1990 Jan; 144(1):386-95. PubMed ID: 2104892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphokine-activated killer (LAK) cells. II. Delineation of distinct murine LAK-precursor subpopulations.
    Ballas ZK; Rasmussen W; van Otegham JK
    J Immunol; 1987 Mar; 138(5):1647-52. PubMed ID: 2879870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precursor phenotype of lymphokine-activated killer cells in the mouse.
    Salup RR; Mathieson BJ; Wiltrout RH
    J Immunol; 1987 Jun; 138(11):3635-9. PubMed ID: 3108370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of long-term cultured activated killer cells induced by anti-T3 antibody.
    Yun YS; Hargrove ME; Ting CC
    J Immunol; 1988 Aug; 141(4):1390-7. PubMed ID: 3260924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine lymphokine-activated killer (LAK) cells: phenotypic characterization of the precursor and effector cells.
    Yang JC; Mulé JJ; Rosenberg SA
    J Immunol; 1986 Jul; 137(2):715-22. PubMed ID: 2873187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional heterogeneity of Leu 19"bright"+ and Leu 19"dim"+ lymphokine-activated killer cells.
    Ellis TM; Fisher RI
    J Immunol; 1989 Apr; 142(8):2949-54. PubMed ID: 2467946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The precursor cells of mouse lymphokine-activated killer (LAK) cells.
    Nishimura T; Yagi H; Uchiyama Y; Hashimoto Y
    Thymus; 1987; 9(3):131-9. PubMed ID: 3495912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.
    Rosenstein M; Yron I; Kaufmann Y; Rosenberg SA
    Cancer Res; 1984 May; 44(5):1946-53. PubMed ID: 6608989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 2 induces human acute lymphocytic leukemia cells to manifest lymphokine-activated-killer (LAK) cytotoxicity.
    Kaufmann Y; Levanon M; Davidsohn J; Ramot B
    J Immunol; 1987 Aug; 139(3):977-82. PubMed ID: 3496395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphokine-activated killer cells. VII. IL-4 induces an NK1.1+CD8 alpha+beta- TCR-alpha beta B220+ lymphokine-activated killer subset.
    Ballas ZK; Rasmussen W
    J Immunol; 1993 Jan; 150(1):17-30. PubMed ID: 7678028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue.
    Donskov F; Basse PH; Hokland M
    Nat Immun; 1996-1997; 15(2-3):134-46. PubMed ID: 9162263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of prothymocyte proliferation by thymic accessory cells.
    Papiernik M; Penit C; el Rouby S
    Eur J Immunol; 1987 Sep; 17(9):1303-10. PubMed ID: 3498636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cultured Lyt-2- L3T4- T lymphocytes from normal thymus or lpr mice express a broad spectrum of cytolytic activity.
    Budd RC; Cerottini JC; MacDonald HR
    J Immunol; 1986 Dec; 137(12):3734-41. PubMed ID: 3491147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of human thymocytes: a limiting dilution analysis of precursors with proliferative and cytolytic activities.
    Lopez-Botet M; Moretta L
    J Immunol; 1985 Apr; 134(4):2299-304. PubMed ID: 3919089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF-alpha potentiation of the lymphokine-activated killer response of murine thymus cells.
    Ujházy P; Maccubbin D; Eppolito C; Mihich E; Ehrke MJ
    Lymphokine Cytokine Res; 1994 Apr; 13(2):99-106. PubMed ID: 8061121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the cytotoxic function of the thymocytes generated in a 14-day old mouse fetal thymus organ culture with high dose of IL-2.
    Leclercq G; de Smedt M; Tison B; Plum J
    Thymus; 1989; 13(1-2):95-102. PubMed ID: 2516374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytolytic and biochemical properties of cytoplasmic granules of murine lymphokine-activated killer cells.
    Henkart PA; Yue CC; Yang J; Rosenberg SA
    J Immunol; 1986 Oct; 137(8):2611-7. PubMed ID: 3489769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.